Apimeds Pharmaceuticals US, Inc. (NYSE: APUS) (“Apimeds”) today announced the expansion of the Apimeds ai² Futures Lab ...

Clinical trials are the cornerstone of medical innovation, playing a vital role in advancing health care and developing new ...

Innovation and Accessibility Fuel the Growth of the Global Generic Drugs MarketThe Global Generic Drugs Market is valued at ...

The event will provide clinical perspectives and market outlook for lacutamab, Innate’s lead proprietary product progressing ...

The aspiration and biopsy needles market represents a critical segment within the global medical devices industry, ...

Carbon 6, a new STEM sixth form at Discovery Park, opens in September 2026 offering A-levels in science and maths with ...

Giovanni Galliano joins Avanzanite having led 12 orphan medicine launches in Italy and overseen operations with more than ...

Cell Therapy Market Expansion Fueled by Rising Adoption of Stem Cell and Gene-Based Therapies WorldwideGlobal Cell Therapy ...

US initiative follows recent CE certification of Ciliatech’s flagship eye implant, Intercil® Uveal Spacer, novel treatment for patients with mild to moderate glaucomaDecisive move unlocks ...

Black Book’s 2026 international survey of 210 health executives highlights a regional push to replace legacy interoperability engines with open, future-proof data architectures. BARCELONA, ES / ACCESS ...

Long-term data on the treatment of children and adults living with Lennox-Gastaut syndrome (LGS) with fenfluramine1 demonstrated sustained reduction in frequency of seizures associated with a fall and ...

Exclusive license via Yeda to two Weizmann Institute patent families from Prof. Nir London’s lab, a leader in covalent drug designSite-specific, durable and traceless protein radiolabeling approaches ...